Issue 10, 2024

Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective

Abstract

Cancer is the uncontrolled proliferation of abnormal cells that invade other areas, spread to other organs, and cause metastases, which is the most common cause of death. A review of all FDA-approved new molecular entities (NMEs) shows that natural products and derivatives account for over one-third of all NMEs. Before 1940, unmodified products and derivatives accounted for 43% and 14% of NME registrations, respectively. Since then, the share of unmodified products has decreased to 9.5% of all approved NMEs, while the share of derivatives has increased to 28%. Since the 1940s, semi-synthetic and synthetic derivatives of natural substances have gained importance, and this trend continues to date. In this study, we have discussed in detail isolated phytoconstituents with chemical modifications that are either FDA-approved or under clinical trials, such as podophyllotoxin, Taxol (paclitaxel, docetaxel), vinca alkaloids (vincristine, vinblastine), camptothecin, genistein, cephalotaxine, rohitukine, and many more, which may act as essential leads to the development of novel anticancer agents. Furthermore, we have also discussed recent developments in the most potent semisynthetic phytoconstituents, their unique properties, and their importance in cancer treatment.

Graphical abstract: Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective

Article information

Article type
Review Article
Submitted
03 May 2024
Accepted
23 Jul 2024
First published
07 Aug 2024

RSC Med. Chem., 2024,15, 3345-3370

Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective

M. Arora, A. K. Singh, A. Kumar, H. Singh, P. Pathak, M. Grishina, J. P. Yadav, A. Verma and P. Kumar, RSC Med. Chem., 2024, 15, 3345 DOI: 10.1039/D4MD00317A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements